Language:

Results 1 - 20 of 36,508 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Peer-reviewed Journals (13,481)

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Abstract 1601 Use of Interactive Progress Curves in an OER to Teach Kinetics in Biochemistry The Journal of biological chemistry, 2024-03, Vol.300 (3) [Peer Reviewed Journal] 2024 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1016/j.jbc.2024.105924 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant (INC) (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S13-S14 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.022 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	NRG-GU012: randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI) The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S12-S13 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.020 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	SAMETA: A Phase III study of savolitinib + durvalumab vs sunitinib and durvalumab monotherapy in patients with MET-driven, unresectable, locally advanced/metastatic papillary renal cell carcinoma The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S11-S12 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.018 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib for previously treated advanced renal cell carcinoma The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S11-S11 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.017 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S12-S12 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.019 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S14-S15 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.024 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC) The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S14-S14 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.023 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S13-S13 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.021 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002 The oncologist (Dayton, Ohio), 2023-08, Vol.28 (Supplement_1), p.S10-S11 [Peer Reviewed Journal] The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.016 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Insights into 2D MXenes for Versatile Biomedical Applications: Current Advances and Challenges Ahead Advanced science, 2018-10, Vol.5 (10), p.1800518-n/a [Peer Reviewed Journal] 2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201800518 ;PMID: 30356929 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	The Assembly of MXenes from 2D to 3D Advanced science, 2020-04, Vol.7 (7), p.1903077-n/a [Peer Reviewed Journal] 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201903077 ;PMID: 32274307 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery Advanced science, 2019-01, Vol.6 (1), p.1801526-n/a [Peer Reviewed Journal] 2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201801526 ;PMID: 30643728 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	T cell responses in patients with COVID-19 Nature reviews. Immunology, 2020-09, Vol.20 (9), p.529-536 [Peer Reviewed Journal] COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-0402-6 ;PMID: 32728222 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Toward Flexible Surface‐Enhanced Raman Scattering (SERS) Sensors for Point‐of‐Care Diagnostics Advanced science, 2019-08, Vol.6 (16), p.1900925-n/a [Peer Reviewed Journal] 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201900925 ;PMID: 31453071 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Plasmonic Photothermal Nanoparticles for Biomedical Applications Advanced science, 2019-09, Vol.6 (17), p.1900471-n/a [Peer Reviewed Journal] 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201900471 ;PMID: 31508273 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	$Modeling the structural relationships of parents\' marital compatibility with students\' academic performance with the mediator role of happiness in high schools for boys in Babol city$ $Modeling the structural relationships of parents\' marital compatibility with students\' academic performance with the mediator role of happiness in high schools for boys in Babol city$ Material Type: Article	Modeling the structural relationships of parents\' marital compatibility with students\' academic performance with the mediator role of happiness in high schools for boys in Babol city مجله علوم روانشناختی, 2023-11, Vol.22 (128), p.1633-1648 [Peer Reviewed Journal] ISSN: 1735-7462 ;EISSN: 2676-6639 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Recruiting rural youth to healthcare careers: A scoping review protocol Canadian medical education journal, 2023-09, Vol.14 (4), p.153-156 [Peer Reviewed Journal] 2023KristinBodell, Trina MFyfe, Sean BMaurice ;2023 Bodell, Fyfe, Maurice; licensee Synergies Partners. 2023 ;ISSN: 1923-1202 ;EISSN: 1923-1202 ;DOI: 10.36834/cmej.76269 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Development of a bilingual interdisciplinary scale assessing self-efficacy for participating in Medical Assistance in Dying Canadian medical education journal, 2023-09, Vol.14 (4), p.157-159 [Peer Reviewed Journal] 2023DianeTapp, ArianePlaisance, NathalieBoudreault, IsabelleSt-Pierre, Jean-FrancoisDesbiens, Sarah-CarolinePoitras, ElizabethLemay, Luis AlejandroUrrea, AmélieLapointe, MelissaHenry, GinaBravo ;2023 Tapp, Plaisance, Boudreault, St-Pierre, Desbiens, Poitras, Lemay, Urrea, Lapointe, Henry, Bravo; licensee Synergies Partners. 2023 ;ISSN: 1923-1202 ;EISSN: 1923-1202 ;DOI: 10.36834/cmej.76161 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	RĂSPUNSURI FĂRĂ ÎNTREBĂRI. AVANCRONICI SUBIECTIVE DESPRE INTELIGENȚA ARTIFICIALĂ Revista de Știinţe Politice şi Relaţii Internaţionale, 2023-09, Vol.XX (3), p.131-139 [Peer Reviewed Journal] ISSN: 1584-1723 ;EISSN: 2285-7540 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by

Results 1 - 20 of 36,508 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Personalize your results

Edit

Add page to My Research

Refine Search Results

Expand My Results

Expand My Results

Show only

Peer-reviewed Journals (13,481)

on this subject:


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Results 1 - 20 of 36,508 for All Library Resources

2024 The American Society for Biochemistry and Molecular Biology, Inc. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1016/j.jbc.2024.105924

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.022

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.020

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.018

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.017

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.019

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.024

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.023

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.021

The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad216.016

2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;ISSN: 2198-3844 ;EISSN: 2198-3844 ;DOI: 10.1002/advs.201800518 ;PMID: 30356929

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-0402-6 ;PMID: 32728222

ISSN: 1735-7462 ;EISSN: 2676-6639

2023KristinBodell, Trina MFyfe, Sean BMaurice ;2023 Bodell, Fyfe, Maurice; licensee Synergies Partners. 2023 ;ISSN: 1923-1202 ;EISSN: 1923-1202 ;DOI: 10.36834/cmej.76269

ISSN: 1584-1723 ;EISSN: 2285-7540

Results 1 - 20 of 36,508 for All Library Resources

Personalize your results

Refine Search Results

Expand My Results

Show only

Refine My Results

Creation Date

New Records

Resource Type

Subject

Databases

Language

Journal Title

on this subject:

Searching Remote Databases, Please Wait